Jeffery Stone - Chairman

Mr. Stone leads the Stone Group and has worked in a wide range of regulated industries and brings financial and regulatory affairs experience to the Indigo Board.

Andrew Dahlem, Ph.D. - Director

Dr. Dahlem is an Executive Vice President at Lilly Research Laboratories, and brings exceptional knowledge of the pharmacuetical industry to the Indigo Board. A successful drug discovery and development researcher, Dr. Dahlem has specific expertise in Drug Disposition and Toxicology.

Bill Johnson - Director

Bill Johnson is President and CEO of Jesubi. Jesubi, founded in 2006, develops and markets solutions for increasing sales productivity. Bill has over 20 years of experience managing and providing technology solutions to a variety of industries.